Relief Therapeutics Holding SA (ETR:RLF) | Finanzwire

Basculer en Français

9473	Companies
185388	Keywords
117743	Articles
99274	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

BRIEF

published on 11/25/2025 at 07:05, 10 days 1 hour ago

Relief Therapeutics and NeuroX Present Financial Outlook for Merger

EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
PRESS RELEASE

published on 11/25/2025 at 07:00, 10 days 1 hour ago

Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets

Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX
BRIEF

published on 11/14/2025 at 18:25, 20 days 14 hours ago

Relief Therapeutics Shareholders Approve Merger with NeuroX

Leadership Changes Shareholder Approval Capital Increase Relief Therapeutics NeuroX Merger
PRESS RELEASE

published on 11/14/2025 at 18:20, 20 days 14 hours ago

Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics shareholders approve business combination with NeuroX, creating a digital neurotherapeutics company. New board members elected. Business combination expected to close in December 2025

Shareholders Business Combination Relief Therapeutics NeuroX Digital Neurotherapeutics
BRIEF

published on 10/29/2025 at 07:05, 1 month 7 days ago

Relief Therapeutics Reports Positive Outcomes in RLF-OD032 Study

FDA Approval RLF-OD032 Phenylketonuria Treatment Bioequivalence Study Sapropterin Dihydrochloride
PRESS RELEASE

published on 10/29/2025 at 07:00, 1 month 7 days ago

Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Relief Therapeutics announces positive results from pivotal bioequivalence study of RLF-OD032, demonstrating bioequivalence to KUVAN®, supporting NDA submission in early 2026

FDA Approval Relief Therapeutics RLF-OD032 Bioequivalence Study PKU Treatment
BRIEF

published on 10/24/2025 at 07:04, 1 month 12 days ago

Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger

Business Combination Extraordinary General Meeting Relief Therapeutics MindMaze Therapeutics NeuroX Group
PRESS RELEASE

published on 10/24/2025 at 06:59, 1 month 12 days ago

Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA

EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA
BRIEF

published on 10/08/2025 at 07:05, 1 month 28 days ago

Relief Therapeutics and NeuroX Finalize Business Combination Agreement

Mergers & Acquisitions NeuroX AI-driven Health Tech Precision Neurology MindMaze Therapeutics
PRESS RELEASE

published on 10/08/2025 at 07:00, 1 month 28 days ago

Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Relief Therapeutics and NeuroX sign definitive agreement for business combination to create MindMaze Therapeutics Holding SA. Transaction poised to advance evidence-based neurotherapeutic solutions and precision medicine

Business Combination Precision Medicine Relief Therapeutics MindMaze NeuroX

1 2 ... 6

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 56 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 1 minute ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 31 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 26 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 31 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 26 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 30 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 30 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 31 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 31 minutes ago

Custodian Property Income REIT plc: Share Buyback

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 31 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 46 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 47 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE